GLP-3R

GLP-3R is a triple-agonist-class incretin research compound offered under a TrueBond Labs coded designation. This pharmacological class comprises single peptides engineered to interact with three metabolic-hormone receptors, an approach that has generated substantial interest in the receptor-pharmacology field. TrueBond Labs carries GLP-3R in three lyophilized strengths — 10mg, 20mg, and 30mg vials — giving laboratories flexibility across pilot experiments and larger analytical campaigns, with each lot independently verified before sale.

Triple-agonist incretin peptides have been the subject of laboratory investigations into multi-receptor pharmacology, comparative signaling studies, and metabolic pathways in preclinical model systems. Analytical chemists have additionally used class members when validating separation and identification methods for complex engineered peptides. TrueBond Labs presents these topics purely as background on where the class appears in the literature; nothing here constitutes a claim of effect, and the product is restricted to research applications.

All three GLP-3R vial sizes come from lot TB-3R-001, whose third-party HPLC purity and mass-spectrometry identity report is posted at /lab-reports, and each release clears the ≥99% purity threshold first. The powder ships lyophilized and stores at −20°C for 24+ months, with reconstituted solutions kept at 2–8°C for around 30 days. In its latest evaluation, the lot measured 99.7% purity on the 10mg reference vial, as recorded on the published certificate.